Eisai Commences Business Activities at New Pharma Sales Subsidiary in Israel
TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that fully-fledged operations and business activities have begun at Eisai […]
TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that fully-fledged operations and business activities have begun at Eisai […]
TOKYO, Jan 19, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that it has been listed in the 2023 Global 100 Most […]
HONG KONG, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has […]
HONG KONG, Dec 17, 2021 – (ACN Newswire via SEAPRWire.com) – 2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards […]
TOKYO, Nov 8, 2021 – (JCN Newswire via SEAPRWire.com) – Several leading Japanese technology firms, including BIRD INITIATIVE, Inc. (hereinafter “BIRD INITIATIVE”)(1), ANA HOLDINGS INC. […]
SINGAPORE (THE BUSINESS TIMES) – iX Biopharma is looking to spin off and list its pharmaceutical and medicinal cannabis business on the mainboard of the […]
HONG KONG, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – Viva Biotech Holdings (1873.HK) announced that during the year ended December 31, 2020 (the […]